K. Malmberg et al., MORTALITY PREDICTION IN DIABETIC-PATIENTS WITH MYOCARDIAL-INFARCTION - EXPERIENCES FROM THE DIGAMI STUDY, Cardiovascular Research, 34(1), 1997, pp. 248-253
Objectives: We analysed predictors of 1-year mortality following acute
myocardial infarction in patients with diabetes mellitus by applying
uni- and multivariate statistics on the DIGAMI cohort. Background: Dia
betic patients with acute myocardial infarction have a poor prognosis,
This may depend on a poor metabolic control, a hypothesis that was te
sted in DIGAMI, a prospective randomised study. In this trial institut
ion of immediate intensive insulin treatment reduced 1-year mortality
by 30%. Methods: We recruited 620 diabetic patients with acute myocard
ial infarction, 314 of whom served as controls, while the remaining 30
6 patients were treated with an acute insulin-glucose infusion followe
d-by multidose subcutaneous insulin. Results: Age, previous myocardial
damage, duration of the diabetes and previous insulin therapy were si
gnificantly related to 1-year mortality, white conventional risk facto
rs lacked independent prognostic weight, Female sex was not linked to
mortality when controlling for the confounding effects of other predic
tors. One of the strongest predictors of a fatal outcome, in particula
r during the hospital phase, was blood glucose at hospital admission.
Beta-blockade appeared to exert a striking, independent secondary-prev
entive effect. Conclusions: It seems that good metabolic control and n
ot conventional risk factors is of major importance for diabetic patie
nts sustaining acute myocardial infarction. Also treatment with beta-b
lockade seems to be of special importance in this category of patients
.